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Abstract
The inner membrane of mitochondria is one of the protein’s richest cellular membranes. The biogenesis of the respiratory chain and ATP-
synthase complexes present in this membrane is an intricate process requiring the coordinated function of various membrane-bound proteins
including protein translocases and assembly factors. It is therefore not surprising that a distinct quality control system is present in this
membrane that selectively removes nonassembled polypeptides and prevents their possibly deleterious accumulation in the membrane. The
key components of this system are two AAA proteases, membrane-embedded ATP-dependent proteolytic complexes, which expose their
catalytic sites at opposite membrane surfaces. Other components include the prohibitin complex with apparently chaperone-like properties
and a regulatory function during proteolysis and a recently identified ATP-binding cassette (ABC) transporter that exports peptides derived
from the degradation of membrane proteins from the matrix to the intermembrane space. All of these components are highly conserved
during evolution and appear to be ubiquitously present in mitochondria of eukaryotic cells, indicating important cellular functions. This
review will summarize our current understanding of this proteolytic system and, in particular, focus on the mechanisms guiding the
degradation of membrane proteins by AAA proteases.
D 2002 Elsevier Science B.V. All rights reserved.
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Maintenance of cell functions requires constant proteol-
ysis in various cellular compartments to remove short-lived
proteins and to prevent the potentially harmful accumulation
of nonnative polypeptides. Various mechanisms have
evolved to ensure the specificity of these proteolytic pro-
cesses including specific tagging devices and sequence-
specific recognition events. A key role in these processes
can be assigned to ATP-dependent proteases that utilize the
energy derived from ATP-hydrolysis for the selective deg-
radation of cellular proteins [1,2]. Whereas a rather detailed
picture of how ATP-dependent proteases recognize and
degrade soluble proteins is emerging, we are only beginning
to understand cellular processes leading to the elimination of
membrane proteins. How are those parts of a protein
degraded, which are embedded in the membrane bilayer,
i.e. reside in a hydrophobic environment? A large energy
demand can be expected for the transfer of membrane-
spanning segments of a protein into a hydrophilic environ-
ment to allow proteolysis to occur. In addition, multispan-
ning membrane proteins often lack large solvent-exposed
loops that could allow the proteolytic attack from the
membrane surface. If solvent-exposed domains are present,
they can reside in different cellular compartments raising the
intriguing question as to how their degradation is coordi-
nated.
1. Degradation of membrane proteins in a cell
Considering the problem of membrane protein degrada-
tion, complete turnover of a membrane protein must be
distinguished from proteolytic processing. Several transcrip-
tion factors are synthesized as dormant membrane proteins
and activated upon cleavage of the solvent-exposed domain
that subsequently enters the nucleus [3,4]. The cytosolic
ubiquitin/proteasome system, for instance, mediates the
processing of the ectodomain of the SPT23 transcription
factor in the membrane of the endoplasmic reticulum (ER)
leading to the reprogramming of the synthesis of unsatu-
rated fatty acids [5]. Though ATP-dependent and tightly
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regulated, this mechanism is reminiscent of the shedding of
cell surface proteins by metalloprotease-disintegrins [6]. In
other cases, proteolytic processing within transmembrane
helices has been observed, which is mediated by dedicated
membrane-embedded proteases and results in the release of
solvent-exposed domains. Examples include SREBP (sterol
regulatory element binding protein), a transcription factor
controlling lipid metabolism, which is cleaved by the metal-
loprotease S2P [7], and the h-amyloid precursor protein,
which seems to be cleaved by the novel membrane-bound
aspartylprotease presenilin [8]. In both cases, intramem-
brane proteolysis is preceded by cleavage of the ectodomain
by yet another protease.
A complete turnover of membrane proteins, on the other
hand, has been observed along various pathways: proteins
of the plasma membrane are ubiquitinated, internalized by
endocytosis and degraded in the lysosomal compartment
[9]. ER membrane proteins are degraded by the ubiquitin/
proteasome system in the cytosol. They are dislocated from
the membrane via the Sec61 translocon, which thus allows
the membrane passage of proteins into and out of the ER
[10]. It is presently not understood how the driving force
required for the retrograde translocation of substrate proteins
into the cytosol is provided. Likely candidates, however, are
the ATPase subunits of the regulatory particle of the
proteasome or ATPases of the VCP/Cdc48/p97 family,
which recently have been linked to the function of the
ubiquitin/proteasome system [11]. In addition, the ubiqui-
tin/proteasome system mediates the turnover of some mem-
brane proteins in the post-Golgi compartment and the
plasma membrane [12], and thus appears to have a central
role in the proteolytic breakdown of membrane proteins in
the cell. The inner membrane of mitochondria, however,
represents a special case, as it is the only cellular membrane
that is not exposed to the cytosolic compartment and there-
fore not accessible for the ubiquitin/proteasome system.
Within this membrane, the so-called AAA proteases con-
stitute yet another cellular pathway for the complete turn-
over of membrane proteins.
2. The family of AAA proteases
AAA proteases form a conserved class of ATP-depend-
ent proteases, members of which are ubiquitous in eubac-
teria and eukaryotic cells [13]. They build up large
membrane-embedded complexes that are composed of
identical or closely related subunits with molecular masses
of 70–80 kDa. The stoichiometry of these subunits in the
complex remains to be established. All known AAA
protease subunits are highly homologous to each other
with sequence identities of >40% between the bacterial,
yeast and human members and share a common domain
structure [13] (Fig. 1). They are anchored by one or two
transmembrane domains in the N-terminal region. AAA
proteases are named after their ATPase domain, typically
200–250 amino acid residues in size, which is character-
istic of a large superfamily of Walker-type P-loop
ATPases, the AAA family (for ATPases associated with a
number of cellular activities) [14,15]. Crystal structures of
various AAA proteins are available that reveal hexameric
ring complexes and a fold of AAA domains as found in
other Walker-type ATPases [16–18]. A conserved amino
acid segment at the C-terminal end of the AAA domain,
which is the signature motif of AAA proteins and is
termed the second region of homology (SRH-region), is
part of the interface between neighbouring protomers.
Therefore, an intermolecular catalytic role of the SRH-
region has been proposed, which is supported by muta-
tional analysis of the SRH-region of Escherichia coli FtsH
[19]. This could also explain the observation that the
ATPase activity of AAA proteins depends on their oligo-
merization [20,21]. Subunits of AAA proteases harbour a
proteolytic domain that is located C-terminal to the AAA
domain. A consensus metal binding site represents the
proteolytic centre identifying AAA proteases as metal-
lopeptidases of the M41 family [22,23]. A helical region
of unknown function, presumably forming a coiled-coil
structure, is present at the extreme C-terminus of AAA
protease subunits.
Similar to AAA proteases, other ATP-dependent pro-
teases can be grouped into conserved protein families.
Common themes are emerging for the mechanisms of
ATP-dependent proteolysis by these peptidases [15]. Firstly,
they all form large assemblies that are thought to form
barrel-shaped microcompartments allowing sequestered pro-
teolysis [2,24]. Secondly, ATP-dependent proteases exploit
the energy derived from ATP-hydrolysis to regulate the
accessibility of the proteolytic sites and to unfold substrates,
allowing their penetration into the proteolytic chamber of
the proteases [25]. Careful multiple sequence alignments
and crystallographic studies revealed striking structural
similarities of the AAA domain with ATPase domains of
Lon- and Clp-proteases. Therefore, the AAA + family has
been defined as an even wider superfamily of ATPases,
which includes AAA proteins as a distinct subfamily char-
acterized by the presence of the SRH-region. The AAA +
domain, which is also found in many proteins with non-
proteolytic functions, is generally thought to exert chaper-
Fig. 1. Domain structure of AAA protease subunits. Two classes of AAA
protease subunits can be distinguished by the number of transmembrane
segments: subunits of m-AAA proteases generally appear to contain two
membrane-spanning domains whereas only one transmembrane segment is
present in all known i-AAA protease subunits. See text for details. MTS,
mitochondrial targeting signal; AAA, ATPase domain; CC, coiled-coil
region.
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one-like activities and to promote protein disassembly or
unfolding reactions [15].
3. The proteolytic system of the mitochondrial inner
membrane
Several AAA proteases exist in eukaryotic cells, where
they seem to be localized exclusively to mitochondria and
chloroplasts. In human and yeast mitochondria, three ortho-
logues of E. coli FtsH are present, whereas at least nine
homologues have been identified in the genome of Arabi-
dopsis thaliana [15,26,27]. The yeast proteins form two
AAA proteases in the mitochondrial inner membrane with a
native molecular mass of f 1 MDa (Fig. 2): the hetero-
oligomeric m-AAA protease composed of Yta10 (Afg3) and
Yta12 (Rca1) subunits is active at the matrix side of the
inner membrane, whereas the i-AAA protease, a homo-
oligomeric complex of Yme1 subunits, is active in the
intermembrane space (Fig. 2). Two AAA proteases with
catalytic sites at opposite membrane surfaces were also
identified in mitochondria of the filamentous fungus Neuro-
spora crassa either of which apparently form homo-oligo-
meric complexes in the inner membrane [28]. Notably,
hydropathy analysis of i-AAA protease subunits of both
organisms suggests the presence of one transmembrane
domain, whereas two membrane-spanning segments appear
to be present in m-AAA protease subunits [13]. AAA
protease subunits with one or two potential transmembrane
domains can be identified by screening human, Drosophila
and plant genome databases suggesting that the membrane
topology of mitochondrial AAA proteases is conserved
throughout evolution [15,26,27]. This conclusion is further
substantiated by complementation studies in yeast, which
revealed a functional conservation between human, N.
crassa and yeast i-AAA proteases [28,29].
4. Cellular functions of mitochondrial AAA proteases
Our current understanding of eukaryotic AAA proteases
is mainly based on studies in yeast and, more recently, also
in the filamentous fungi N. crassa, which revealed severe
phenotypes associated with mutations in AAA protease
subunits. Most strikingly, yeast cells lacking both m- and
i-AAA proteases are not viable, demonstrating the crucial
function of this proteolytic system for cellular homeostasis
[30,31]. Both proteases thus exert overlapping functions
within mitochondria, which, however, are not identical as
indicated by different phenotypes of mutations in m- or i-
AAA protease subunits.
The i-AAA protease Yme1 was first identified in a genetic
screen as a yeast mutant having an increased rate of DNA
escape from mitochondria to the nucleus [32]. Yeast cells
lacking YME1 or expressing a proteolytically inactive variant
of Yme1 are respiratory deficient at high temperature, exhibit
a cold-sensitive growth defect on complete glucosemedia and
grow poorly whenmitochondrial DNA is deleted. In addition,
accumulation of punctate mitochondria was observed in the
absence of Yme1, suggesting a role of Yme1 in the main-
tenance of mitochondrial morphology [33]. The molecular
basis of the various phenotypes caused by inactivation of
Yme1 is presently unclear. Most likely, multiple proteolytic
substrates exist in mitochondria reflecting the various defects
associated with a yme1 mutation. Each of the various pheno-
types can apparently be suppressed individually. For example,
mutations in the mitochondrial ATP-synthase g-subunit sup-
press the slow growth phenotype of yme1 mutants lacking
mitochondrial DNA [34]. On the other hand, the cold-sensi-
tive phenotype of Dyme1 cells can be suppressed by mutation
of YME2, another mitochondrial inner membrane protein
[35]. This view is supported by a recent phenotypic analysis
of an N. crassa mutant lacking the i-AAA protease IAP-1
[28]. Similarly to yeast cells, iap-1 mutant cells exhibited a
slow growth phenotype at high temperature. However,
defects in mitochondrial morphology were not observed in
these cells. Thus, differences in the physiological function of
i-AAA proteases between various organisms must be consid-
ered. Nevertheless, when expressed in Dyme1 yeast cells,
IAP-1 could substitute for the function of Yme1 in maintain-
ingmitochondrial morphology pointing to a rather degenerate
substrate specificity [28].
Deletion of either YTA10 (AFG3) or YTA12 (RCA1)
impairs the respiratory competence of the cells reflecting
the requirement of the m-AAA protease for at least two steps
during the biogenesis of respiratory complexes in the inner
membrane: firstly, the m-AAA protease controls the expres-
sion of two respiratory chain subunits, cytochrome oxidase
subunit 1 (Cox1) and cytochrome b (Cob), which both are
encoded by intron-containing genes in the mitochondrial
genome of yeast [36]. Splicing of COX1 and COB transcripts
is impaired after inactivation of the m-AAA protease, while
transcription and translation can also proceed in the absence
of Yta10 andYta12. Interestingly, the function of the protease
Fig. 2. The proteolytic system of the mitochondrial inner membrane. Yeast
orthologues of various complex subunits are indicated in brackets. See text
for details. IMS, intermembrane space; IM, mitochondrial inner membrane.
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appears to be confined to introns encoding mRNAmaturases.
As these proteins are synthesized as inactive proenzymes in
yeast, it is an attractive possibility that the m-AAA protease
mediates the proteolytic processing of these precursor forms
(see Ref. [37] for a comprehensive review). An additional
function of the m-AAA protease was suggested by the
observation that the expression of COX1 and COB but not
the respiratory competence of the cells was restored upon
removal of introns from the mitochondrial genome [36]. The
m-AAA protease thus also affects the posttranslational
assembly of respiratory chain complexes. Similarly, the
assembly of the FOF1-ATP synthase was found to depend
on the m-AAA protease [38]. As the targets of the protease
have not been identified, its role in the assembly processes is
not understood on the molecular level.
Considering their strong sequence conservation, similar
functions of mitochondrial AAA proteases in higher eukary-
otic cells are conceivable. Inactivation of the human AAA
protease paraplegin was found to cause neurodegeneration
in a recessive form of hereditary spastic paraplegia (HSP)
[39]. Muscle biopsies of affected individuals revealed an
impaired oxidative phosphorylation, in agreement with the
essential function of the m-AAA protease for the biogenesis
of respiratory chain complexes in yeast. As the human
mitochondrial genome lacks introns [40], paraplegin might
act solely on the posttranslational level.
It should be noted, however, that the molecular basis of
cellular defects observed after inactivation of AAA pro-
teases in yeast or human are presently not clear. As identical
phenotypes were observed for yeast cells in the absence of
AAA proteases or after mutation of their proteolytic sites,
the deficiencies can be attributed to the loss of proteolytic
activity [36,41,42]. An impaired mitochondrial activity
could therefore be the consequence of an altered stability
of specific substrate proteins with regulatory functions
during mitochondrial biogenesis. This might include an
inhibited processing of specific regulatory proteins.
Although short-lived substrates of mitochondrial AAA
proteases have not been identified, they nevertheless might
exist as mutant AAA protease variants with low proteolytic
activity were sufficient to suppress growth defects of the
respective null-mutant cells [22,23]. Alternatively, mis-
folded polypeptides accumulating in the absence of AAA
proteases could inhibit mitochondrial functions. Along this
line, the progressive nature of HSP in humans could be
explained by the increase of mitochondrial mutations that
occur upon aging and the concomitant accumulation of
nonnative respiratory chain subunits in mitochondria.
5. Mechanism of membrane protein degradation by
AAA proteases
The quality control function of mitochondrial AAA pro-
teases in the inner membrane has been exploited in the past to
examine the function of AAA proteases on the molecular
level. Substrates of AAA proteases include various non-
assembled inner membrane proteins, which all are integral
part of the inner membrane, but the degradation of periph-
erally associated proteins is also conceivable. Similar to other
ATP-dependent proteases, both AAA proteases appear to
have a rather broad substrate specificity. The involvement
of one or the other (or both) AAA proteases in proteolysis of
an inner membrane protein depends solely on its membrane
topology [30]. Whereas the i-AAA protease degrades non-
assembled subunit 2 of the cytochrome oxidase complex
(Cox2) [43,44], the mitochondrially encoded respiratory
chain subunits Cox1, Cox3 andCob as well as the FO subunits
6, 8 and 9 of the ATP synthase were identified as substrates of
the m-AAA protease [22,23]. Proteins, like the inner mem-
brane protein Yme2, with a solvent-exposed domain exposed
to bothmembrane surfaces can be degraded by either them- or
the i-AAA protease. Deletion of either YTA10 or YME1 does
not significantly affect the turnover rate of nonnative Yme2
[30]. It remains to be determined, however, whether or not
both AAA proteases cooperate during proteolysis of such
substrate proteins in vivo.
What is the mechanism of membrane protein degradation
by AAA proteases? Mitochondrial AAA proteases exert
chaperone-like properties, monitor the folding state of sol-
vent-exposed domains and specifically degrade nonnative
membrane proteins [45]. Notably, degradation by AAA
proteases depends on the unfolding of protein domains on
both membrane surfaces [30]. The AAA-ATPase domain
mediates the interaction with unfolded membrane proteins
and thereby ensures the specificity of proteolysis [45]. In
view of the conserved membrane topology of both AAA
proteases in the mitochondrial inner membrane, one might
expect that AAA proteases solely degrade solvent-exposed
loops and domains of target proteins on the same membrane
side. Removal of loop regions including charged amino acid
residues flanking transmembrane segments might destabilize
membrane-embedded regions of a substrate protein, allow-
ing their degradation from the membrane surface. Although
such a shedding mechanism is conceivable and not yet
excluded to occur under certain circumstances, recent studies
suggest a dislocation of substrate polypeptides from the
membrane for proteolysis by AAA proteases [30]. The
synthetic lethality of yeast mutations in YTA10 and YME1
provided first evidence for an overlapping substrate specif-
icity of mitochondrial AAA proteases, which were subse-
quently indeed found to be capable of degrading subdomains
of substrate proteins present at the opposite membrane sur-
face. However, the minimum length of a solvent-exposed
stretch that can still be recognised by the AAA protease on
the same side of the membrane is f 20 amino acid residues
[30]. This restriction in their ability to recognize and bind
substrate proteins might explain why m- and i-AAA pro-
teases cannot completely substitute each other.
The dislocation of substrate proteins from the membrane
for proteolysis raises the intriguing question of how hydro-
philic domains initially present at the opposite membrane
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surfaces traverse the inner membrane. Numerous studies on
protein transport across cellular membranes have demon-
strated the requirement of proteinaceous hydrophilic pores
for the translocation process [46]. The turnover of mem-
brane proteins in the endoplasmic reticulum (ER) is medi-
ated by the 26 S proteasome in the cytosol and involves the
retrograde translocation of substrates across the ER mem-
brane via the Sec61 translocase [10,47] (Fig. 3). Similarly,
protein translocases of the inner membrane, like the TIM17/
23-, the TIM22- or the OXA1-complexes [48,49], might
allow the dislocation of membrane proteins for degradation
by AAA proteases. Alternatively, a hydrophilic pore might
be formed by the transmembrane segments of AAA protease
subunits, which build up large oligomeric complexes (Fig.
3). There is currently no structural information on mito-
chondrial AAA proteases available. However, electron
microscopic images of the E. coli AAA protease FtsH
suggest a ring-like structure similar to other ATP-dependent
proteases that bind and degrade substrates in a sequestered
proteolytic chamber [50]. If membrane-embedded AAA
proteases would indeed bind substrates in an inner cavity
of a ring-like complex, the accessibility of the proteolytic
sites would most likely require complex alterations in their
oligomeric structure. Such conformational changes of AAA
protease subunits could be driven by the AAA domains,
which presumably also provide the energy for the disloca-
tion process during proteolysis. Notably, AAA proteins,
including the ATPase subunits of the 19 S regulatory
complex and Cdc48/VCP, have also been proposed to drive
the retrograde translocation of ER membrane proteins via
the Sec61 channel, indicating further analogies between
both proteolytic processes [11].
6. Role of prohibitins during membrane protein
degradation
The yeast m-AAA protease is part of a supercomplex in
the inner membrane with a native molecular mass larger
than f 2000 kDa [51]. It assembles with prohibitins,
which form another multimeric protein complex composed
of Phb1 and Phb2 subunits. Prohibitins comprise an
apparently ubiquitous, highly conserved protein family in
eukaryotic cells [52]. Two homologous proteins have been
identified in various organisms, which were localized to
the mitochondrial inner membrane [53–55]. Both are
anchored to the inner membrane by one transmembrane
segment close to the N-terminus, whereas the majority of
the proteins is exposed to the intermembrane space. The
first member was identified in mammals due to its anti-
proliferative effect and overexpression in various primary
human tumors. Accordingly, a potential role of prohibitins
in tumor suppression has been proposed [56], which is
controversially discussed [57].
Deletion of prohibitin genes in yeast caused an accel-
erated degradation of nonassembled membrane proteins
by the m-AAA protease [51]. Overexpression of Phb1 and
Phb2, on the other hand, was found to stabilize nonnative
polypeptides against degradation [58]. Prohibitins there-
fore seem to exert a regulatory function during membrane
protein turnover by the m-AAA protease. This is sup-
ported by genetic experiments revealing a dramatic syn-
thetic growth phenotype of cells lacking both the m-AAA
protease and prohibitins [51]. Notably, prohibitins are
enriched in the periphery of mitochondria but almost
absent from cristae membrane upon immunogold labelling
of mammalian mitochondria [55]. This could indicate a
local inhibition of the m-AAA protease in close proximity
to protein import sites by prohibitins, which might have a
scaffolding function within the inner membrane. The
activity of prohibitins on the molecular level, however,
is still unclear. A direct interaction of prohibitins with
nonassembled respiratory chain subunits was observed
upon overexpression [58]. Prohibitins could therefore
interfere with proteolysis by directly binding to substrate
proteins. A similar function has been proposed for the
distantly related E. coli proteins HlfK and HflC, which
were found in association with the bacterial AAA pro-
tease FtsH [59].
The functional interaction of prohibitins with the m-
AAA protease raises the intriguing question of whether
cellular activities previously attributed to prohibitins are
linked to the degradation of mitochondrial inner membrane
proteins. Yeast cells lacking prohibitins grow normally but
have a decreased replicative life span, reminiscent of
observations in mammalian cells [54]. Moreover, genetic
evidence indicates that prohibitins have a role in mito-
chondrial inheritance [53]. Further studies are awaited to
establish whether prohibitins exert regulatory functions
linked to membrane protein degradation by AAA proteases
or nonproteolytic roles in these apparently unrelated cel-
lular processes. The notion that prohibitins share homolo-
gous protein domains with stomatins, flottillins and plant
disease response proteins may help in these studies
[60,61].
Fig. 3. Hypothetical models for the dislocation of membrane proteins by
AAA proteases. Membrane extraction of substrates may either be mediated
by AAA proteases themselves or may occur via protein translocases of the
inner membrane (left panel). The latter model would be similar to the
degradation of ER membrane proteins by the 26 S proteasome (right panel).
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7. Export of peptides generated by AAA proteases from
mitochondria
Early studies have established that the mitochondrial
proteolytic system is capable of degrading organellar pro-
teins to amino acid residues [62]. Proteolysis of nonas-
sembled mitochondrially encoded respiratory chain subunits
initiated by AAA proteases was recently found to result in
the formation of a heterogenous spectrum of peptides and
free amino acid residues within mitochondria [63]. Strik-
ingly, these proteolytic products are released from the
organelle. Two pathways for the efflux of peptides com-
posed of more than approximately 10 amino acid residues
can be distinguished, which converge in the intermembrane
space (Fig. 4): first, peptides generated by the m-AAA
protease in the matrix space are actively transported across
the inner membrane by a novel mitochondrial ABC trans-
porter, Mdl1. Mdl1 is a half-type ABC-protein and highly
homologous to the transporter associated with antigen
presentation (TAP) in higher eukaryotic cells, which trans-
ports similar-sized peptides into the lumen of the ER
[64,65]. Second, proteolysis of inner membrane proteins
by the i-AAA protease results in the release of peptides
directly in the intermembrane space. Peptides could then
cross the mitochondrial outer membrane by passive diffu-
sion, most likely either through porins or the TOM-com-
plex, the general protein import pore of the outer membrane
[48]. It is presently unclear whether mitochondrial pepti-
dases other than AAA proteases are involved in the gen-
eration of peptides within the organelle. It should be noted,
however, that peptides did not accumulate within
Dmdl1Dyme1 mutant mitochondria, suggesting a competi-
tion between the export of long peptides from and their
complete degradation to amino acid residues within mito-
chondria.
The physiological role of peptides exported from mi-
tochondria remains to be elucidated. The presence of ho-
mologous ABC transporters [66–69] in mammalian
mito-chondria suggests that similar pathways exist also in
mitochondria of higher eukaryotic cells. Notably, peptides
derived from mitochondrially encoded membrane proteins
have been detected at the cell surface of mammalian cells
where they are presented by class I MHC (Major Histo-
compatibility Complex) molecules [70,71]. It is an attractive
hypothesis that mitochondrially encoded minor histocom-
patibility antigens are generated by AAA proteases within
mitochondria and then released to the cytosol, from where
they enter the conventional class I antigen presentation
pathway. While it is conceivable that exported mitochon-
drial peptides are exploited by the immune system for
immune surveillance in mammals, our results in yeast point
to additional cellular functions of mitochondrial peptide
export. These may include signaling mechanisms akin to
quorum sensing in bacteria [72] to allow coordination of
mitochondrial and nuclear gene expression. Signaling path-
ways from mitochondria to the nucleus in response to partial
depletion or loss of mitochondrial DNA have been
described in yeast [73,74] as well as in human cells
[75,76]. It will be interesting to see whether mitochondrial
protein export plays any role in these signalling pathways.
8. Perspectives
During the last few years, a distinct quality control
system has been identified in the mitochondrial inner
membrane that ensures the selective removal of nonas-
sembled precursors of mitochondrial inner membrane pro-
teins. Many issues still remain to be addressed. To
understand the molecular mechanism underlying the bio-
logical effects of the mitochondrial AAA proteases, it will
be crucial to identify short-lived physiological substrates for
both proteases. Prohibitins have been described both as
tumor suppressor genes in the mammalian system as well
as regulators of AAA proteases in yeast mitochondria. By
elucidating the molecular mechanism of prohibitin action, a
broader understanding of the cellular function of the mito-
chondrial AAA protease system will be conceivable. Fur-
thermore, the biological role of mitochondrial protein export
has to be explored as mitochondrially derived peptides
could be major players in the signal transduction events
between the mitochondria and the nucleus. Most of the data
have been generated in the yeast Saccharomyces cerevisiae,
although the quality control system of mitochondrial AAA
proteases is highly conserved in evolution. It will be
important to study the molecular mechanisms described in
yeast mitochondria also in higher organisms especially as
human orthologues for AAA proteases as well as prohibitins
have been linked to disease.
Fig. 4. Pathways of peptide export from mitochondria. See text for details.
OM, mitochondrial outer membrane; IMS, intermembrane space; IM, inner
membane.
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